Category: Pharmacy & Distribution
North America Pharmacy & Distribution
-
Ragweed Pollen Allergy Treatment Market, by Drug Class (Antihistamines, Decongestants, Nasal Corticosteroids, and Others), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Channel), and by Region (North America, Latin America, Euro
... East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Ragweed pollen is considered as one of the most common roots of seasonal allergies, especially in the U.S. The pollen present in ... Read More
-
North America Carbapenem-Based Antibiotics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Meropenem, Doripenem, Imipenem, Tebipenem, and Others), Indication (Bacterial Meningitis, Acute Pelvic Infections, Respiratory Tract Infections, Intra-Abdominal Infections, Urinary Tract Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies)
... Infections, and Others), and Distribution Channel (Retail Pharmacies, Online Pharmacies, and Hospital Pharmacies) The North America carbapenem-based antibiotics market is expected to reach US$ 1,713.21 million by 2028 from US$ 1,244.59 million in 2021; it ... Read More
-
United States of America (USA) Over-the-Counter (OTC) Healthcare Market Size by Categories, Distribution Channel, Market Share and Forecast, 2021-2026
... growth markets to target, trends in the usage of category level distribution data and companies market shares. The US OTC healthcare sector is led by the vitamins and minerals category in value terms in 2021. ... Read More
-
Canada Over-the-Counter (OTC) Healthcare Market Size by Categories, Distribution Channel, Market Share and Forecast, 2021-2026
... trends in the usage of category level distribution data and companies market shares. The Canadian OTC healthcare sector was led by cold and cough preparations in value terms. However, the vitamins and minerals category is ... Read More
-
U.S. Sterile Injectables Market, by Molecule Type (Large Molecule and Small Molecule), by Drug Type (Monoclonal Antibody (mAbs), Cytokines, Insulin, Peptide Hormones, Vaccines, Immunoglobulin’s, Blood Factors, Peptide Antibiotics, and Others), by Therapeutic Application (Cancer, Metabolic Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Diseases, Cardiovascular Diseases, Central Nervous System Disorder, Infectious Diseases, Musculoskeletal Disorders, and Others), by Route of Administration (Subcutaneous (SC), Intravenous (IV), Intramuscular (IM), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online ... Read More
-
Pyrimethamine Market, by Indication (Toxoplasmosis, Malaria, and Others), by Route of Administration (Parenteral and Oral), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Pyrimethamine is a medicine used to treat protozoan infections. Pyrimethamine belongs to a class of drugs known as antiparasitics. It works ... Read More
-
U.S. Real-World Evidence (RWE) Solutions Market by Component [Datasets (Clinical, Claims, Pharmacy, Integrated), Services], Application (Market Access, Oncology, Neurology, Post Market Surveillance), End User (Pharma Companies, Providers) - Forecast to 2028
... grow at a CAGR of 13.0% from 2021 to 2028 to reach $2.01 billion by 2028 Following a thorough secondary and primary research and in-depth analysis of the market scenario, the report carries out the ... Read More
-
Meningococcal Disease Treatment Market, By Therapy Type (Antibiotics (Penicillin, Ampicillin, Chloramphenicol, and Ceftriaxone) and (Vaccines (Bivalent, Trivalent, and Tetravalent)), By Route of Administration (Injectable and Oral), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, and Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028 Meningococcal infection is a bacterial infection caused by Neisseria meningitidis, also ... Read More
-
U.S. E-Prescribing Market - Industry Outlook & Forecast 2022-2027
... grow at a CAGR of 20.68% during the period 2022–2027. U.S. E-PRESCRIBING INDUSTRY INSIGHTS E-prescribing uses healthcare technologies to improve prescription accuracy, enhance patient safety, and ensure cost savings. Also, e-prescribing allows real-time, secure, and ... Read More
-
Pharmacy Market Size, Share & Trends Analysis Report By Product Type (Prescription, OTC), By Pharmacy Type (Retail, ePharmacy), By Region (North America, APAC), And Segment Forecasts, 2022 - 2028
... View Research, Inc. Rapid growth in the ePharmacy market is a major parameter driving the market. Drastic growth in the online purchases of medicines during the COVID-19 pandemic along with increasing adoption of digital technologies ... Read More
Research Assistance
